GRP78 Inhibitor YUM70 Suppresses SARS-CoV-2 Viral Entry, Spike Protein Production and Ameliorates Lung Damage
Viruses · 06.05.2023 · 15 (5) · 1118
DOI: 10.3390/v15051118 ↗Kurz gefasst
Fachartikel in der Zeitschrift Viruses, online erschienen am 06.05.2023. Verfasst von Dat P Ha und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry and Molecular Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, NIAAA NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of the COVID-19 pandemic, has given rise to many new variants with increased transmissibility and the ability to evade vaccine protection. The 78-kDa glucose-regulated protein (GRP78) is a major endoplasmic reticulum (ER) chaperone that has been recently implicated as an essential host factor for SARS-CoV-2 entry and infection. In this study, we investigated the efficacy of YUM70, a small molecule inhibitor of GRP78, to block SARS-CoV-2 viral entry and infection in vitro and in vivo. Using human lung epithelial cells and pseudoviral particles carrying spike proteins from different SARS-CoV-2 variants, we found that YUM70 was equally effective at blocking viral entry mediated by original and variant spike proteins. Furthermore, YUM70 reduced SARS-CoV-2 infection without impacting cell viability in vitro and suppressed viral protein production following SARS-CoV-2 infection. Additionally, YUM70 rescued the cell viability of multi-cellular human lung and liver 3D organoids transfected with a SARS-CoV-2 replicon. Importantly, YUM70 treatment ameliorated lung damage in transgenic mice infected with SARS-CoV-2, which correlated with reduced weight loss and longer survival. Thus, GRP78 inhibition may be a promising approach to augment existing therapies to block SARS-CoV-2, its variants, and other viruses that utilize GRP78 for entry and infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry and Molecular Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
- Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
- Florida Research and Innovation Center, Cleveland Clinic, Port St. Lucie, FL 34987, USA.
- Department of Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
- Department of Medicinal Chemistry, College of Pharmacy and Rogel Cancer Center, University of Michigan, Ann Arbor, MI 48109, USA.
- Department of Pathology, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
ORCID-Profile: Dat P Ha, Keigo Machida
Förderung
- NIH HHS
- NIAAA NIH HHS
- NCI NIH HHS
- W. M. Keck Foundation
- NIH
- Korea Research Institute of Bioscience and Biotechnology (KRIBB) Research Initiative Program
Zitieren
APA
Ha, D. P., Shin, W. J., Hernandez, J. C., Neamati, N., Dubeau, L., Machida, K., & Lee, A. S. (2023). GRP78 Inhibitor YUM70 Suppresses SARS-CoV-2 Viral Entry, Spike Protein Production and Ameliorates Lung Damage. Viruses, 15(5), 1118. https://doi.org/10.3390/v15051118
Vancouver
Ha DP, Shin WJ, Hernandez JC, Neamati N, Dubeau L, Machida K, et al. GRP78 Inhibitor YUM70 Suppresses SARS-CoV-2 Viral Entry, Spike Protein Production and Ameliorates Lung Damage. Viruses. 2023;15(5):1118. doi:10.3390/v15051118
BibTeX
@article{Ha2023,
author = {Ha, Dat P and Shin, Woo-Jin and Hernandez, Juan Carlos and Neamati, Nouri and Dubeau, Louis and Machida, Keigo and Lee, Amy S},
title = {GRP78 Inhibitor YUM70 Suppresses SARS-CoV-2 Viral Entry, Spike Protein Production and Ameliorates Lung Damage},
journal = {Viruses},
year = {2023},
volume = {15},
number = {5},
pages = {1118},
doi = {10.3390/v15051118}
}
EUVIMED